Final External Expert Advisory Board meeting held in Lisbon

At the start of the LLJ project, a board of experts (EEAB) was appointed to be our ‘critical friends’.

Since 2015 it has met with representatives of the project annually to receive information about progress on developments and to give the project team an opportunity to hear external expert opinion. Four of the six members of the Board were present : Professor Maria Grazia Benedetti – Professor at the Ospedale Universitario Rizzoli Istituto Ortopedico Rizzoli in Bologna; Professor Tom Joyce – Professor of Orthopaedic Engineering Mechanical and Systems Engineering, University of Newcastle; Professor Dr. Frank Lampe – Professor at the Schön Klinik Hamburg Eilbek, Zentrum für Endoprothetik; and  Dr Catherine Van Der Straeten – Head of the Clinical Research and Innovation Institute and Network Ghent University Hospital, Ghent, Belgium Honorary Senior Clinical Lecturer Imperial College London, UK.

The presentations focussed on the results of the coating development and future plans for exploitation presented by Antonio Santana Global Head Segment Medical at Ionbond; Prof. Stephen Ferguson  and doctoral student Enrico De Pieri from ETH presented on “Advances in computational methods and impact on treatment strategies” and Dr David Lunn from Leeds Teaching Hospitals NHS Trust presented on “Stratified approaches in Clinical Motion Analysis”.

These presentations stimulated an intensive exchange on future directions of work in implant replacement, but there was particular praise for the advances made musculoskeletal modelling software systems with Prof. Lampe expressing appreciation for the fact that this will allow surgeons to take a more individualistic approach.

LLJ wraps up in Lisbon

The last week of the project grant period is a busy week for the project in Lisbon. Project Members gathered here to hold a special workshop at the 15th International Symposium on Computer Methods in Biomechanics and Biomedical Engineering (CMBBE).

On Sunday 25 March the final Partner Assembly was held. Presentations were given by researchers on key results of the projects. The final deliverables were discussed and signed off followed by a session looking ahead at possible future projects on topics proposed from the LLJ work. Many participants are old hands at EU projects and everyone was in agreement that LLJ had been a particularly harmonious project with exceptionally good working relations between partners.

LLJ moving into its final phase reaches consensus on exploitation scenarios

LLJ held a technical discussion meeting at ETH Zürich 1-2 November focussing on reviewing the coating development and test results. Since commencement of the project the market for hard-on-hard implants has collapsed to be replaced largely by hard on polyethylene systems. This has posed some questions about which product scenarios should now be the focus of the project work to offer the best exploitation opportunities. In concluding the meeting, the scientific coordinator Prof. Richard Hall noted the tremendous progress that had been made and the consensus established around how to move forward to the conclusion of the project.

Very good progress has been made over the past 12 months!

This was the key observation made by the Project Technical Assistant Laurence Archibald at the third LLJ annual review meeting held in Manchester 8 June.

Work package leaders presented the achievements of the past 12 months and the ongoing work. The coating development is proceeding towards final specification; there are exciting developments in the area of simulation and modelling; a new method for the toxicology measurements has been achieved; over 50 scientific presentations and paper submissions have been made; LLJ young researchers have received awards; a very successful outreach event was held.


In commending the progress made, Laurence Archibald, stressed now the importance of preparing for exploitation. Monica Schofield speaking for the work of WP6 which tackles Medical device regulation, exploitation, dissemination pointed out that the work was being carried out in accordance with a Regulatory Plan defined at the start of the project which is intended to smooth the route too exploitation of the coating on implants, though commercial support for this cannot be guaranteed. There is certainly a lot of exploitation interest in the modelling and simulation work.

LLJ partners are pleased with the positive feedback from the PTA. It is very helpful to the project to have a competent external view on developments.

8th Partner Assembly held in Manchester, European City of Science

Manchester was the location for the 8th LLJ Partner Assembly meeting at the end of February. The Partner Assembly meets twice a year to bring together project community for representatives of each of the work packages to get up to date with the progress in the project as a whole.
The project is now entering the exciting phase when things are coming together. There was discussion around the properties and specification of the coating, as well as discussion of the plans for dissemination.


Manchester will be hosting the EuroScience Open Forum 2016, 23-27 July.